Orient Pharma Co (ROCO:4166) ROE % Adjusted to Book Value : 0.26% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Orient Pharma Co ROE % Adjusted to Book Value?

Orient Pharma Co's ROE % for the quarter that ended in Dec. 2024 was 1.16%. Orient Pharma Co's PB Ratio for the quarter that ended in Dec. 2024 was 4.49. Orient Pharma Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 0.26%.

Orient Pharma Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Orient Pharma Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Pharma Co ROE % Adjusted to Book Value Chart

Orient Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.95

-2.84

-0.73

0.61

1.38

Orient Pharma Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.42	0.01	1.00	3.33	0.26

Competitive Comparison of Orient Pharma Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Pharma Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orient Pharma Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Pharma Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Orient Pharma Co's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Orient Pharma Co ROE % Adjusted to Book Value Calculation

Orient Pharma Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	6.21%	/	4.49
	=	1.38%

Orient Pharma Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.16%	/	4.49
	=	0.26%

Orient Pharma Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Orient Pharma Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Pharma Co Ltd (ROCO:4166) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Kehu 1st Road, Huwei Town, Yunlin County, Central Science Park, Taipei, TWN, 106

Website

http://www.oppharma.com

Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.

Orient Pharma Co Headlines

No Headlines